Researchers examined 100 patients with chronic lateral epicondylitis assigned to a leukocyte enriched PRP group or the corticosteroid group. The PRP group was more often successfully treated than the corticosteroid group where success was defined as a 25 percent reduction on the visual analog scale and disabilities scores.
At the two-year follow-up, both groups had significantly improved. The disability scores of the corticosteroid group returned to baseline levels while the PRP group significantly improved. There were no complications reported in the PRP group.
Read the abstract about treating chronic lateral epicondylitis with PRP.
Read other coverage on PRP:
– AAOS: PRP an Unproven Option for Orthopedic Treatment
– Study: PRP Not Effective for Treating Achilles Tendon Ruptures
– World Anti-Doping Agency Will Allow PRP for Athletes in 2011
